Cargando…
The role of specific antibody in alternative complement pathway- mediated opsonophagocytosis of type III, group B Streptococcus
The native capsular polysaccharide antigen of type III, group B Streptococcus contains a terminal sialic acid residue on each repeating unit that masks all end-group galactopyranose residues and prevents alternative pathway complement activation by adult human sera in the absence of type-specific an...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2185859/ https://www.ncbi.nlm.nih.gov/pubmed/6989947 |
Ejemplares similares
-
Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals
por: Muri, Lukas, et al.
Publicado: (2021) -
Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study
por: Leung, Stephanie, et al.
Publicado: (2023) -
The Protease SplB of Staphylococcus aureus Targets Host Complement Components and Inhibits Complement-Mediated Bacterial Opsonophagocytosis
por: Dasari, Prasad, et al.
Publicado: (2022) -
Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
por: Thomas, Stephen R., et al.
Publicado: (2018) -
Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b
por: Muri, Lukas, et al.
Publicado: (2022)